Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-bromophenyl-1-amino Adamantane
2. Bromontan
1. 87913-26-6
2. Bromantan
3. N-(4-bromophenyl)adamantan-2-amine
4. N-(2-adamantyl)-n-(4-bromophenyl)amine
5. Ladasten
6. 2-(4-bromophenyl)aminoadamantane
7. N1ils53xwk
8. Tricyclo[3.3.1.13,7]decan-2-amine,n-(4-bromophenyl)-
9. N-(4-bromophenyl)tricyclo(3.3.1.13,7)decan-2-amine
10. Tricyclo(3.3.1.13,7)decan-2-amine, N-(4-bromophenyl)-
11. Bromontan
12. Tricyclo[3.3.1.13,7]decan-2-amine, N-(4-bromophenyl)-
13. Unii-n1ils53xwk
14. 2-bromophenyl-1-amino Adamantane
15. Bromantane [who-dd]
16. Schembl737152
17. Chembl4303520
18. Dtxsid40405333
19. Albb-035069
20. Zinc2577057
21. N-(4-bromophenyl)-2-adamantanamine
22. Akos004120981
23. Akos037644786
24. As-54469
25. N-(2-adamantyl)-n-(p-bromophenyl)-amine
26. Db-082762
27. S10385
28. A842407
29. Q385533
30. Z1736662073
| Molecular Weight | 306.24 g/mol |
|---|---|
| Molecular Formula | C16H20BrN |
| XLogP3 | 5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 305.07791 g/mol |
| Monoisotopic Mass | 305.07791 g/mol |
| Topological Polar Surface Area | 12 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 280 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Cholinergic Agents
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage. (See all compounds classified as Cholinergic Agents.)
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
ABOUT THIS PAGE
87
PharmaCompass offers a list of Bromantane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bromantane manufacturer or Bromantane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bromantane manufacturer or Bromantane supplier.
PharmaCompass also assists you with knowing the Bromantane API Price utilized in the formulation of products. Bromantane API Price is not always fixed or binding as the Bromantane Price is obtained through a variety of data sources. The Bromantane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromantane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromantane, including repackagers and relabelers. The FDA regulates Bromantane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromantane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bromantane supplier is an individual or a company that provides Bromantane active pharmaceutical ingredient (API) or Bromantane finished formulations upon request. The Bromantane suppliers may include Bromantane API manufacturers, exporters, distributors and traders.
Bromantane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromantane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromantane GMP manufacturer or Bromantane GMP API supplier for your needs.
A Bromantane CoA (Certificate of Analysis) is a formal document that attests to Bromantane's compliance with Bromantane specifications and serves as a tool for batch-level quality control.
Bromantane CoA mostly includes findings from lab analyses of a specific batch. For each Bromantane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromantane may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromantane EP), Bromantane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromantane USP).
